Sort
23,748 grants matching “melanoma”
Engineered T Cell Therapy for Melanoma
$339,874Robert H Vonderheide · Wistar Institute · P50 · FY2016 · CA
A Unified Machine Learning Package for Cancer Diagnosis
$339,842Linda Shapiro · University Of Washington · U01 · FY2018 · CA
Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma
$339,818Jeffrey M. Trent · Translational Genomics Research Inst · R01 · FY2009 · CA
Community Outreach and Engagement
$339,811Karen Marie Winkfield · Vanderbilt University Medical Center · P30 · FY2025 · CA
IN VITRO/IN VIVO ACTIVATED DENDRITIC CELLS FOR MELANOMA
$339,799University Of Southern California · R01 · FY2001 · CA
Lymphatic Imaging
$339,782Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Nucleoporin NUP205-driven Novel Pathway in Melanoma Tumor Growth and Metastasis
$339,694Narendra Wajapeyee · University Of Alabama At Birmingham · R01 · FY2020 · CA
A NOVEL DRUGGABLE GENETIC VULNERABILITY PATHWAY IN MELANOMA
$339,694Narendra Wajapeyee · University Of Alabama At Birmingham · R01 · FY2020 · CA
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
$339,661Georg T Wondrak · University Of Arizona · R01 · FY2019 · CA
Radiation Affects Tumor Antigen Presentation
$339,644University Of California Los Angeles · R01 · FY2004 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$339,625Ryan M Teague · Saint Louis University · R01 · FY2023 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$339,625Ryan M Teague · Saint Louis University · R01 · FY2022 · CA
Anti-Cancer Activities of PTPase Inhibitors
$339,482Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
Anti-Cancer Activities of PTPase Inhibitors
$339,482Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA
Cancer and Leukemia Group B
$339,417Dana-Farber Cancer Institute · U10 · FY2005 · CA
Mechanism of Resistance to Arginine Deiminase Therapy in Advance Melanoma
$339,391Macus T Kuo · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
MECHANISMS OF ALCOHOL RELATED INHIBITION OF NK ACTIVITY
$339,363Washington State University · R01 · FY2000 · AA
Genetic Approaches to Immune Adjuvants
$339,352Alan N. Houghton · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Melanoma detection by optical spectroscopy
$339,306Lihong Wang · Washington University · R01 · FY2007 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$339,297Jeffrey S Weber · New York University School Of Medicine · R01 · FY2017 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$339,297Jeffrey S Weber · New York University School Of Medicine · R01 · FY2016 · CA
Establishing the Preclinical Model for Metastatic Melanoma
$339,253Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Deciphering macroH2A function in melanoma progression
$339,155Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · CA
Molecular connections among UV exposure, red hair, nevi and melanoma
$339,093Rutao Cui · Boston University Medical Campus · R01 · FY2018 · CA
The role of pheomelanin in cutaneous melanoma
$339,090Rutao Cui · Boston University Medical Campus · R01 · FY2012 · CA